QI
EW icon

Qtron Investments’s Edwards Lifesciences EW Stock Holding History

Qtron Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,912
Closed -$269K – 442
2024
Q2 		$269K Hold
2,912
– – 0.04% 414
2024
Q1 		$278K Hold
2,912
– – 0.04% 441
2023
Q4 		$222K Hold
2,912
– – 0.04% 446
2023
Q3 		$202K Sell
2,912
-1,802
-38% -$145K 0.04% 393
2023
Q2 		$445K Hold
4,714
– – 0.08% 299
2023
Q1 		$390K Buy
4,714
+1,802
+62% +$142K 0.08% 316
2022
Q4 		$217K Hold
2,912
– – 0.05% 391
2022
Q3 		$241K Sell
2,912
-2,046
-41% -$197K 0.06% 369
2022
Q2 		$471K Buy
+4,958
New +$513K 0.1% 261
2021
Q4 		– Sell
-4,963
Closed -$562K – 340
2021
Q3 		$562K Buy
+4,963
New +$566K 0.15% 203

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Qtron Investments's EW Position: Q3 2024 in Review

Qtron Investments sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 2,912 shares — an estimated $269K sold.

Qtron Investments first reported a position in EW in Q3 2021 and held it in 10 quarters. The position peaked at $562K in Q3 2021. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Qtron Investments reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Qtron Investments sold 2,912 Edwards Lifesciences shares in Q3 2024, an estimated $269K.
  • Qtron Investments first reported a position in Edwards Lifesciences in Q3 2021 and held it in 10 quarters.
  • Qtron Investments's Edwards Lifesciences position peaked at $562K in Q3 2021.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Qtron Investments's 13F filing for Q3 2024, filed 13 Nov 2024.